Synaptic protein α1-takusan mitigates amyloid-β-induced synaptic loss via interaction with tau and postsynaptic density-95 at postsynaptic sites

N Nakanishi, SD Ryan, X Zhang, A Khan… - Journal of …, 2013 - Soc Neuroscience
N Nakanishi, SD Ryan, X Zhang, A Khan, T Holland, EG Cho, X Huang, FF Liao, H Xu
Journal of Neuroscience, 2013Soc Neuroscience
The synaptic toxicity of soluble amyloid-β (Aβ) oligomers plays a critical role in the
pathophysiology of Alzheimer's disease (AD). Here we report that overexpressed α1-
takusan, which we previously identified as a protein that enhances synaptic activity via
interaction with PSD-95, mitigates oligomeric Aβ-induced synaptic loss. In contrast, takusan
knockdown results in enhanced synaptic damage. α1-Takusan interacts with tau either
directly or indirectly, and prevents Aβ-induced tau hyperphosphorylation and mitochondrial …
The synaptic toxicity of soluble amyloid-β (Aβ) oligomers plays a critical role in the pathophysiology of Alzheimer's disease (AD). Here we report that overexpressed α1-takusan, which we previously identified as a protein that enhances synaptic activity via interaction with PSD-95, mitigates oligomeric Aβ-induced synaptic loss. In contrast, takusan knockdown results in enhanced synaptic damage. α1-Takusan interacts with tau either directly or indirectly, and prevents Aβ-induced tau hyperphosphorylation and mitochondrial fragmentation. Deletion analysis identified the second domain (D2) within the takusan protein that is required for PSD-95 clustering and synaptic protection from Aβ. A 51 aa sequence linking D2 to the PDZ-binding C terminus was found to be as effective as full-length takusan in protecting synapses from Aβ-induced damage. Moreover, a sequence containing the D2 from the human protein discs large homolog 5, when linked to a C-terminal PDZ-binding motif, can also increase the clustering of PSD-95 in cortical dendrites. In summary, α1-takusan protects synapses from Aβ-induced insult via interaction with PSD-95 and tau. Thus, takusan-based protein sequences from either mouse or human may be of potential therapeutic benefit in AD.
Soc Neuroscience
以上显示的是最相近的搜索结果。 查看全部搜索结果